Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

6.13
-0.2100-3.31%
Post-market: 6.230.1000+1.63%19:30 EDT
Volume:835.40K
Turnover:5.21M
Market Cap:118.56M
PE:-1.01
High:6.68
Open:6.59
Low:6.06
Close:6.34
52wk High:20.56
52wk Low:6.06
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.12
T/O Rate:4.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.16
PE(LYR):-1.04

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Apr 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 23

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

GlobeNewswire
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 17

Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections

TIPRANKS
·
Apr 17

Corbus CEO Cohen base salary rises to $673,625 under amended employment agreement

Reuters
·
Apr 17

Corbus Pharmaceuticals announces last person enrolled in CANYON-1 trial

TIPRANKS
·
Apr 14

Corbus enrolls last patient in Phase 1b CANYON-1 obesity trial of CRB-913

Reuters
·
Apr 14

Corbus Pharmaceuticals Holdings Inc - Canyon-1 Study on Track for Completion in Summer 2026

THOMSON REUTERS
·
Apr 14

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 14

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Corbus Pharmaceuticals (CRBP) and Avita Medical (RCEL)

TIPRANKS
·
Apr 09

Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
Apr 09

Corbus Pharmaceuticals (CRBP) Gets a Buy from Wedbush

TIPRANKS
·
Apr 08

Corbus Pharmaceuticals Holdings Inc. Stock Slips 4.2%, Underperforms Market

Dow Jones
·
Apr 08

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)

TIPRANKS
·
Apr 07

Corbus reports FDA alignment for CRB-701, CMO Dominic Smethurst departure

TIPRANKS
·
Apr 07

Corbus CMO Dominic Smethurst to step down June 30, 2026

Reuters
·
Apr 07

BRIEF-Corbus Pharmaceuticals Announces Broad Alignment With FDA On Registration Path For Crb-701 In Second-Line Hnscc And Cervical Cancer

Reuters
·
Apr 07